Question

A 58-year-old with HFrEF (LVEF 30%) on sacubitril/valsartan and metoprolol succinate remains symptomatic (NYHA II). Creatinine 1.0 mg/dL, K+ 4.5 mEq/L, eGFR 70 mL/min/1.73 m². Which evidence-based addition reduces mortality and HF hospitalization?

Accepted Answer

Spironolactone

Answer

Diltiazem

Answer

Ivabradine

Answer

Hydralazine alone

Answer

Verapamil

Practice question

A 58-year-old with HFrEF (LVEF 30%) on sacubitril/valsartan and metoprolol succinate remains symptomatic (NYHA II). Creatinine 1.0 mg/dL, K+ 4.5 mEq/L, eGFR 70 mL/min/1.73 m². Which evidence-based addition reduces mortality and HF hospitalization?